Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-03-05 Sale | 2020-03-09 7:37 pm | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 2,076 | $62.86 | $130,498 | 4,470 (Direct) | View |
2020-02-18 Sale | 2020-02-20 6:25 pm | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 1,313 | $69.71 | $91,529 | 7,845 (Direct) | View |
2020-02-06 Sale | 2020-02-10 7:49 pm | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 4,562 | $72.14 | $329,089 | 2,595 (Direct) | View |
2020-02-03 Sale | 2020-02-04 8:47 pm | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 3,845 | $63.75 | $245,133 | 137,930 (Direct) | View |
2020-01-27 Sale | 2020-01-29 4:47 pm | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 781 | $71.15 | $55,568 | 6,704 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-02-21 Option Award | 2023-02-23 5:02 pm | N/A 2033-02-20 | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 600,000 | $0 | 600,000 (Direct) | View |
2022-02-16 Option Award | 2022-02-18 7:02 pm | N/A 2032-02-15 | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 650,000 | $0 | 650,000 (Direct) | View |
2021-01-13 Option Award | 2021-07-01 7:00 pm | N/A 2031-01-12 | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 1,510,007 | $0 | 2,691,440 (Direct) | View |
2021-01-16 Exercise | 2021-07-01 7:00 pm | N/A N/A | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 374,013 | $0.3 | 2,691,440 (Direct) | View |
2021-03-11 Option Award | 2021-07-01 7:00 pm | N/A N/A | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 19,763 | $5.06 | 2,691,440 (Direct) | View |
2021-06-29 Conversion | 2021-07-01 7:00 pm | N/A N/A | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 27,889 | $0 | 2,691,440 (Direct) | View |
2021-01-16 Exercise | 2021-07-01 7:00 pm | N/A 2031-01-12 | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 374,013 | $0 | 2,691,440 (Direct) | View |
Ownership | 2021-06-24 9:19 pm | N/A N/A | Graphite Bio Inc. | GRPH | Lehrer-Graiwer Joshua PRESIDENT AND CEO | 0 | $0 | 1,956,866 (Direct) | View |
2020-03-09 Exercise | 2020-03-09 7:37 pm | N/A 2026-09-07 | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 938 | $0 | 4,470 (Direct) | View |
2020-03-09 Exercise | 2020-03-09 7:37 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 938 | $19.89 | 4,470 (Direct) | View |
2020-03-01 Exercise | 2020-03-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 1,750 | $0 | 7,233 (Direct) | View |
2020-03-01 Tax Withholding | 2020-03-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 612 | $63.96 | 7,233 (Direct) | View |
2020-02-18 Exercise | 2020-02-20 6:25 pm | N/A 2027-02-16 | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 1,313 | $0 | 7,845 (Direct) | View |
2020-02-18 Exercise | 2020-02-20 6:25 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 1,313 | $26.9 | 7,845 (Direct) | View |
2020-02-10 Exercise | 2020-02-10 7:49 pm | N/A 2026-02-08 | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 625 | $0 | 2,595 (Direct) | View |
2020-02-10 Exercise | 2020-02-10 7:49 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 625 | $12.95 | 2,595 (Direct) | View |
2020-02-03 Exercise | 2020-02-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 1,657 | $59.6 | 137,930 (Direct) | View |
2020-02-03 Option Award | 2020-02-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 62,660 | $0 | 137,930 (Direct) | View |
2020-02-03 Exercise | 2020-02-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 2,188 | $48.44 | 137,930 (Direct) | View |
2020-01-31 Option Award | 2020-02-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 579 | $36.68 | 137,930 (Direct) | View |
2020-02-01 Exercise | 2020-02-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 16,045 | $0 | 137,930 (Direct) | View |
2020-02-01 Tax Withholding | 2020-02-04 8:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 2,163 | $65.26 | 137,930 (Direct) | View |
2020-01-27 Exercise | 2020-01-29 4:47 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 781 | $27.9 | 6,704 (Direct) | View |
2020-01-27 Exercise | 2020-01-29 4:47 pm | N/A 2027-07-25 | Global Blood Therapeutics Inc. | GBT | Lehrer-Graiwer Joshua Chief Medical Officer | 781 | $0 | 6,704 (Direct) | View |